Advemto

Advemto’s 2D molecular barcode reader, the MatriX-1, an ultrafast photoluminescence spectrometer, allows labs to identify hundreds of biomarkers at once, a significant improvement over traditional fluorescent labelling methods. Traditional methods are limited to identifying only a few biomarkers at a time, resulting in long, expensive development processes.

Advemto’s technology addresses this by converting fluorescent signals into 2D barcodes, enabling faster and more accurate biomarker identification. This accelerates drug development, improves clinical diagnostics, and allows for the merging of data across different trials.